Frailty assessment in geriatric radiation oncology.


Journal

Advances in cancer research
ISSN: 2162-5557
Titre abrégé: Adv Cancer Res
Pays: United States
ID NLM: 0370416

Informations de publication

Date de publication:
2024
Historique:
medline: 22 9 2024
pubmed: 22 9 2024
entrez: 21 9 2024
Statut: ppublish

Résumé

Older adults with cancer are at risk of over-treatment or under-treatment, and treatment decision-making is difficult due to both the complexity of adverse aging and under-representation in clinical trials. It is recommended to perform a frailty assessment before treatment decision-making. Although the importance of radiotherapy increases in geriatric oncology, there is less evidence base information on frailty assessment in radiation oncology than in medical/surgical oncology. The present literature review analyzed the available data regarding frailty assessment tools in geriatric radiation oncology. The predictive value of geriatric assessment on survival outcomes has been shown in many cancer subtypes treated with radiotherapy. Additionally, the Geriatric-8 score is the most evidenced screening tool in frailty assessment. However, researches are ongoing on the cut-off points of geriatric screening tools and which one is the best. Prospective randomized controlled trials are required for the integration of geriatric screening tools and geriatric assessment-driven interventions into geriatric radiation oncology practice.

Identifiants

pubmed: 39306368
pii: S0065-230X(24)00069-1
doi: 10.1016/bs.acr.2024.07.003
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

283-309

Informations de copyright

Copyright © 2024. Published by Elsevier Inc.

Auteurs

Rahmi Atil Aksoy (RA)

Department of Radiation Oncology, Izmir City Hospital, İzmir, Turkey. Electronic address: atilaksoy07@gmail.com.

Vildan Kaya (V)

Department of Radiation Oncology, Medstar Antalya Hospital, Antalya, Turkey; Antalya Bilim University, Antalya, Turkey.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH